You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 256 No. 17, November 7, 1986 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis

M. H. Stoler, T. A. Eskin, S. Benn, R. C. Angerer and L. M. Angerer

Patients with the acquired immunodeficiency syndrome (AIDS) are subject to a spectrum of central nervous system (CNS) disorders. Recent evidence implicates the human T-cell lymphotropic virus type III (HTLV-III) in the pathogenesis of some of these illnesses, although, the cells infected by the virus have yet to be identified. Using in situ hybridization, we examined brain tissue from two patients with AIDS encephalopathy for the presence of HTLV-III RNA. In both cases, viral RNA was detected and concentrated in, though not limited to, the white matter. The CNS cells most frequently infected included macrophages, pleomorphic microglia, and multinucleated giant cells. Less frequently, cells morphologically consistent with astrocytes, oligodendroglia, and rarely neurons were also infected. The findings strengthen the association of HTLV-III with the pathogenesis of AIDS encephalopathy. In situ hybridization can be applied to routinely prepared biopsy tissue in the diagnosis of HTLV-III infection of the CNS.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

HIV-1 and HIV-Associated Nephropathy 25 Years Later
Wyatt and Klotman
CJASN 2007;2:S20-S24.
ABSTRACT | FULL TEXT  

Oligodendrocyte-Specific Expression of Human Immunodeficiency Virus Type 1 Nef in Transgenic Mice Leads to Vacuolar Myelopathy and Alters Oligodendrocyte Phenotype In Vitro
Radja et al.
J. Virol. 2003;77:11745-11753.
ABSTRACT | FULL TEXT  

Human immunodeficiency virus type 2
Reeves and Doms
J. Gen. Virol. 2002;83:1253-1265.
FULL TEXT  

The Synthetic Immunomodulator Murabutide Controls Human Immunodeficiency Virus Type 1 Replication at Multiple Levels in Macrophages and Dendritic Cells
Darcissac et al.
J. Virol. 2000;74:7794-7802.
ABSTRACT | FULL TEXT  

Blood-Brain Barrier Tight Junction Disruption in Human Immunodeficiency Virus-1 Encephalitis
Dallasta et al.
Am. J. Pathol. 1999;155:1915-1927.
ABSTRACT | FULL TEXT  

Interleukin-16 Inhibits Human Immunodeficiency Virus Type 1 Entry and Replication in Macrophages and in Dendritic Cells
Truong et al.
J. Virol. 1999;73:7008-7013.
ABSTRACT | FULL TEXT  

Neuronal Death Induced by Brain-Derived Human Immunodeficiency Virus Type 1 Envelope Genes Differs between Demented and Nondemented AIDS Patients
Power et al.
J. Virol. 1998;72:9045-9053.
ABSTRACT | FULL TEXT  

C-C Chemokines Released by Lipopolysaccharide (LPS)-stimulated Human Macrophages Suppress HIV-1 Infection in Both Macrophages and T Cells
Verani et al.
J. Exp. Med. 1997;185:805-816.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.